SCHEMBL25870579

SCHEMBL25870579

Cc1cc2ccc(-c3ccc(C(=O)O)cc3)cc2cc1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.76
KMT2A Q03164 3/20 0.76
THRB P10828 1/20 0.76
RECQL P46063 1/20 0.76
NR2E1 Q9Y466 1/20 0.76
RARB P10826 14/20 0.63
RARG P13631 14/20 0.63
RARA P10276 13/20 0.63
KDM4E B2RXH2 1/20 0.63
ALDH1A1 P00352 1/20 0.63
TP53 P04637 1/20 0.63
CYP3A4 P08684 1/20 0.63
MAPT P10636 1/20 0.63
HPGD P15428 1/20 0.63
ALOX15 P16050 1/20 0.63
ALOX12 P18054 1/20 0.63
MAPK1 P28482 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
HSD17B10 Q99714 1/20 0.63
NR1I2 O75469 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL444659 0.86 RARG (0.76) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL173380 0.86 MEN1 (1.00) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL29359220 0.86 MEN1 (1.00) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8900666 0.85 RARB (0.78) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7926641 0.84 MEN1 (0.70) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8439716 0.83 MEN1 (0.69) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL9010769 0.82 MEN1 (0.71) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7926644 0.81 MEN1 (0.70) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7920626 0.81 MEN1 (0.66) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7920630 0.80 RARG (0.79) MEN1KMT2ATHRBRECQLNR2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11707442-B2 Antibacterial and antifungal compounds THE GENERAL HOSPITAL CORPORATION (US) 2023-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11707442-B2 Antibacterial and antifungal compounds RXRA, VDR, RXRB MEN1 3858/4885KMT2A 3841/4885THRB 1760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.